收稿日期: 2019-04-01
网络出版日期: 2019-06-25
基金资助
国家自然科学基金(81741103);上海市卫生和计划生育委员会科研基金(201640368);上海市卫生和计划生育委员会科研基金(2016ZB0103-01)
Report of a case of activated phosphoinositide 3-kinase δ syndrome with onset of repeated bloody stool and review of literature
Received date: 2019-04-01
Online published: 2019-06-25
目的: 观察1例以反复便血起病的PIK3CDδ过度活化综合征(activated phosphoinositide 3-kinase δ syndrome,APDS)患儿的临床及结肠镜表现,并进行基因检测,分析其特征,为该病的诊断提供参考。方法: 总结分析1例发病时表现为血便的APDS患儿的临床表现及生化指标检测、基因检测、结肠镜检查、组织病理检查结果和治疗、随访情况,并在中文数据库及PubMed数据库中检索相关文献进行综合探讨。结果: 患儿为1岁7个月的女童,以黏液血便起病,6个月间诊断肠道感染4次;实验室检查示血清免疫球蛋白水平降低(IgG 1.16 g/L,IgA 0.11 g/L,IgM 2.81 g/L),血淋巴细胞免疫分型提示CD4+T淋巴细胞百分比下降,CD8+T淋巴细胞百分比升高(CD3+ 61.30%,CD3+ CD4+ 26.30%,CD3+ CD8+ 33.80%,CD56+ CD16+ 27.80%,CD19+ 10.40%);电子结肠镜检查见较多颗粒样淋巴滤泡增生(nodular lymphonodular hyperplasia,NLH);全外显子组测序发现其PIK3CD基因存在c.3061G>A(p.E1021K)点突变。检索相关文献显示,APDS患者以反复呼吸道感染,巨细胞病毒和(或)EB病毒感染,淋巴组织增生为主要表现。结论: 本例患儿为国内首次发现的以便血为首发症状的APDS。临床对于低龄、反复便血,尤其肠镜下可见NLH者,应注意检查其是否合并免疫指标异常,并与原发性免疫缺陷病鉴别,而通过相关基因检测可确诊APDS。
杨媛艳, 肖园, 陈晓炎, 苏雯, 许春娣, 张清清 . PIK3CDδ过度活化综合征一例并文献复习[J]. 诊断学理论与实践, 2019 , 18(03) : 296 -300 . DOI: 10.16150/j.1671-2870.2019.03.010
Objective: To investigate the clinical features, endoscopic appearance and genetic characteristic of a child with activated phosphoinositide 3-kinase δ syndrome (APDS) with onset of recurrent bloody stools. Methods: A 19-month-old girl who was diagnosed with APDS because of PIK3CD mutation was admitted into Ruijin Hospital in December 2018. The clinical manifestations, biochemical tests, immunological function, treatment, and follow-up of the patient were analyzed.And Chinese database and PUBMED database were searched for literature review. Results: The child had chronic diarrhea and suffered intestinal infection for 4 times. Serum immunoglobulin levels were decreased: IgG 1.16 g/L,IgA 0.11 g/L, IgM 2.81 g/L. The T cell subset detection found increased CD8+ and decreased CD4+: CD3+ 61.30%, CD3+CD4+ 26.30%, CD3+CD8+ 33.80%, CD56+CD16+ 27.80%, CD19+10.40%. Colonoscopy found lymphonodular hyperplasia. A mutation of c.3061G>A(p.E1021K) in PIK3CD gene was found by whole-exome sequencing. Related literature searched showed that APDS patients had repeated respiratory infections, CM virus and/or EB virus infection, lymphoid tissue hyperplasia as the main manifestations. Conclusions: This is the first report of a case of APDS with onset of recurrent bloody stool in our country. For low aged children who has repeated bloody stools, especially those with lymphonodular hyperplasia found under colonoscopy, should have abnormal immunological findings tested and differentiated from primary immunodeficiency diseases.APDS could be diagnosed by relevant genetic test.
[1] | Angulo I, Vadas O, Garçon F, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage[J]. Science, 2013, 342(6160):866-871. |
[2] | 唐文静, 王薇, 罗颖, 等. PIK3CD基因突变致PI3Kδ过度活化综合征临床及免疫学特点分析[J]. 中华儿科杂志, 2017, 55(1):19-24. |
[3] | Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424. |
[4] | Teranishi H, Ishimura M, Koga Y, et al. Activated phosphoinositide 3-kinase δ syndrome presenting with gut-associated T-cell lymphoproliferative disease[J]. Rinsho Ketsueki, 2017, 58(1):20-25. |
[5] | Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study[J]. J Allergy Clin Immunol, 2017, 139(2):597-606. |
[6] | Sullivan KE, Conrad M, Kelsen JR. Very early-onset inflammatory bowel disease: an integrated approach[J]. Curr Opin Allergy Clin Immunol, 2018, 18(6):459-469. |
[7] | Elkaim E, Neven B, Bruneau J, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study[J]. J Allergy Clin Immunol, 2016, 138(1):210-218. |
[8] | Dulau Florea AE, Braylan RC, Schafernak KT, et al. Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD[J]. J Allergy Clin Immunol, 2017, 139(3):1032-1035. |
[9] | Sinclair LV, Finlay D, Feijoo C, et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking[J]. Nat Immunol, 2008, 9(5):513-521. |
[10] | Dornan GL, Siempelkamp BD, Jenkins ML, et al. Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1[J]. Proc Natl Acad Sci U S A, 2017, 114(8):1982-1987. |
[11] | Burke JE, Vadas O, Berndt A, et al. Dynamics of the phosphoinositide 3-kinase p110δ interaction with p85α and membranes reveals aspects of regulation distinct from p110α[J]. Structure, 2011, 19(8):1127-1137. |
[12] | Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency[J]. Nat Immunol, 2014, 15(1):88-97. |
/
〈 |
|
〉 |